1
2
3
4
5
6
7
8
9
10
11
12
13 | On 7/29/21 Licensing Program Analyst (LPA) Shaunte Henry conducted an unannounced visit to initiate an investigation into the above allegations. The LPA met with Executive Director (ED), Cheree Escandel, explained the nature of the visit and was granted entry.
The investigation, which consisted of document review and interviews revealed the following:
Allegation #1: Staff are over medicating a resident while in care:
Resident 1 (R1) changed hospice agencies and the new hospice agency prescribed Morphine because R1 stated they had neck and back pain. R1 was already prescribed Tramadol. R1 received both medications on 7/16/21, 7/17/21, 7/18/21 and 7/19/21. On 7/19/21 Staff 1 (S1) observed R1 to be lethargic and immediately contacted the hospice agency. The Morphine was immediately discontinued due to R1 having a history of Transient Ischemic Attacks (TIA)s, which was a risk factor. R1 immediately began recovering after the Morphine was discontinued.
***continued on 9099C*** |